ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Krystal Biotech Inc

Krystal Biotech Inc (KRYS)

173.35
-3.04
(-1.72%)
Closed February 27 3:00PM
173.35
-0.009
(-0.01%)
After Hours: 6:50PM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
125.0047.3051.100.0049.200.000.00 %00-
130.0042.3046.200.0044.250.000.00 %00-
135.0037.6041.300.0039.450.000.00 %00-
140.0032.6036.500.0034.550.000.00 %00-
145.0027.8031.700.0029.750.000.00 %00-
150.0023.1027.0036.0025.050.000.00 %00-
155.0019.1022.4033.5820.750.000.00 %00-
160.0015.1018.3028.7016.700.000.00 %0203-
165.0012.1014.6022.0513.350.000.00 %061-
170.008.3011.7020.0010.000.000.00 %0310-
175.005.509.4016.007.450.000.00 %01,013-
180.003.307.506.005.40-1.00-14.29 %301012/27/2025
185.001.905.605.853.75-4.85-45.33 %1532/27/2025
190.001.204.903.303.05-2.23-40.33 %115432/27/2025
195.000.154.202.002.175-0.40-16.67 %122/27/2025
200.000.053.602.201.8250.000.00 %022-
210.000.003.000.000.000.000.00 %00-
220.001.502.551.502.0250.000.00 %01-
230.000.002.350.000.000.000.00 %00-

Professional-Grade Tools, for Individual Investors.

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
125.000.002.300.000.000.000.00 %00-
130.000.002.350.000.000.000.00 %00-
135.000.002.450.000.000.000.00 %00-
140.001.002.551.001.7750.000.00 %02-
145.0010.422.7010.426.560.000.00 %01-
150.000.452.901.031.6750.000.00 %0201-
155.000.053.603.051.8250.000.00 %05-
160.000.504.502.502.500.000.00 %0200-
165.002.055.700.003.8750.000.00 %00-
170.003.507.608.005.550.000.00 %02-
175.006.9010.407.508.653.5087.50 %1352/27/2025
180.009.6012.606.6011.100.000.00 %05-
185.0013.0017.0010.4515.00-0.000.00 %04-
190.0016.8020.809.0018.800.000.00 %01-
195.0021.0025.000.0023.000.000.00 %00-
200.0025.5029.400.0027.450.000.00 %00-
210.0034.8038.8030.0036.800.000.00 %01-
220.0044.1049.000.0046.550.000.00 %00-
230.0054.1059.000.0056.550.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PEPGPepGen Inc
US$ 2.51
(64.05%)
26.55M
ULYUrgent ly Inc
US$ 0.6715
(59.88%)
154.71M
BCGBinah Capital Group Inc
US$ 2.845
(53.11%)
69.86M
RRGBRed Robin Gourmet Burgers Inc
US$ 6.09
(34.73%)
3.92M
LBGJLi Bang International Corporation Inc
US$ 1.8601
(30.99%)
974.97k
SUNESUNation Energy Inc
US$ 0.4224
(-63.27%)
5.49M
SPGCSacks Parente Golf Inc
US$ 0.401
(-45.23%)
19.69M
DMRCDigimarc Corporation
US$ 15.35
(-43.23%)
1.57M
NXTTNext Technology Holding Inc
US$ 0.77
(-41.22%)
7.2M
ARKOARKO Corporation
US$ 4.515
(-37.81%)
5.83M
NVDANVIDIA Corporation
US$ 120.15
(-8.48%)
443.6M
QNRXQuoin Pharmaceuticals Ltd
US$ 0.356499
(15.82%)
161.75M
ULYUrgent ly Inc
US$ 0.6715
(59.88%)
154.71M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 12.465
(-6.21%)
147.14M
TRNRInteractive Strength Inc
US$ 1.525
(22.00%)
126.97M

KRYS Discussion

View Posts
Monksdream Monksdream 4 months ago
KRYS. Under $200
👍️0
Monksdream Monksdream 7 months ago
KRYS new 52 week high
👍️0
Monksdream Monksdream 10 months ago
KRYS 10Q due 5/6
👍️0
Monksdream Monksdream 11 months ago
KRYS over $30
👍️0
Monksdream Monksdream 12 months ago
KRYS new 52 week high
👍️0
Monksdream Monksdream 2 years ago
From Cathie Wood
A Novel Gene Therapy Promises Relief For A Rare Genetic Skin Disorder
ARK Invest_Illustration_Pierce Jamieson_Final_Circle 400 px By Pierce Jamieson | @PierceARK
Research Associate
Recently, the US Food and Drug Administration (FDA) approved Krysta Biotech’s (KRYS) groundbreaking advance1 in gene therapy, Vyjuvek, to treat wounds in patients suffering from dystrophic epidermolysis bullosa (DEB), a rare and serious genetic skin disorder caused by mutations in the collagen Type VII alpha 1 chain (COL7A1) gene. As the first FDA-approved gene therapy for DEB, Vyjuvek is a significant breakthrough.

Vyjuvek uses a genetically modified HSV-1 to deliver normal copies of the COL7A1 gene to wounds, restoring the integrity of the skin with fibrils that hold skin layers together. Treated with Vyjuvek, 65% of wounds closed completely.
👍️0
wiredawg wiredawg 3 years ago
Moving nicely today...
👍️0
wiredawg wiredawg 3 years ago
Looking at the few posts here there seems to be no real commitment here...any thoughts on KRYS? Hype or something brewing?
👍️0
wiredawg wiredawg 3 years ago
In the last 3 months, 5 ranked analysts set 12-month price targets for KRYS. The average price target among the analysts is $125.00. Analysts compare their price target to the current market price of the stock to determine how much potential upside or downside movement there could be in the stock price. High $140 Low $111

👍️0
wiredawg wiredawg 3 years ago
30 Nov Tues releases this PR during evening after market close:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-pricing-200-million-public-offering
👍️0
wiredawg wiredawg 3 years ago
29 Nov Mon after market closes release this PR:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-proposed-200-million-public-offering
👍️0
wiredawg wiredawg 3 years ago
29 Nov Monday pre-market news release, great move pre-market approx 7am and so far holding fairly well:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-positive-topline-results-gem-3-pivotal
👍️0
wiredawg wiredawg 3 years ago
This caught my eye on Monday, the huge move off the PR...I'm guessing here saw the same. Any real thoughts regarding the company and this PR. I have not gotten a chance to dig into it. Hoping to have somm DD done over the weekend.
👍️0
wiredawg wiredawg 3 years ago
Holding well so far, why the pretty hard drop?
👍️0
wiredawg wiredawg 3 years ago
Why are you surprised? Serious question, not being impudent...
👍️0
rynlrt rynlrt 3 years ago
200 million dollar offering. Won't be surprised to see it drop pretty hard when the market opens
👍️0
Fofo812 Fofo812 3 years ago
Surprised it held up this long
👍️0
crudeoil24 crudeoil24 3 years ago
Large tutes holdings. Some taking huge gains before years end.
👍️0
rynlrt rynlrt 3 years ago
Not sure this kind of gain is sustainable. May see a big pullback
👍️0
Fofo812 Fofo812 3 years ago
3rd post
👍️0
crudeoil24 crudeoil24 3 years ago
Krystal Biotech shares are trading higher after the company announced its GEM-3 trial met its primary endpoint.
👍️0
Trophy Trophy 5 years ago
..
👍️0

Your Recent History

Delayed Upgrade Clock